ArticleThe Journal of clinical investigation2015

Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Jiro Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.